Pharmesol
Coppell, US · 2 known investors
Pharmesol builds a network of AI agents that automate manual, fragmented processes across healthcare systems and workflows, aiming to make medications safer and easier for patients and clinicians. The platform handles routine operational tasks and turns interactions into insights for care teams.
Founders & leadership
Investors · 2
Competitors · 2
by search overlapMedMe Health4 shared keywordsMedMe builds a pharmacy-specific electronic health record platform with AI-powered clinical documentation and Medicare Part B billing infrastructure for community pharmacies in the United States. The platform enables pharmacists to document and bill for clinical services including immunizations, counseling, and chronic care management that are already being delivered but largely unbilled.
Parata3 shared keywordsParata provides pharmacy automation products including pouch and blister medication adherence packaging, high-speed robotic dispensing systems, and pharmacy workflow software. It serves health system, retail, long-term care, Department of Defense, nutraceutical, and central fill pharmacies.
Companies competing with Pharmesol for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements$160K disclosed across 1 of 2 rounds · 2023–2025
▶$1.3MofferedMar 2025 · BiotechnologyRule 506(b)
▶$1.3MofferedMar 2025 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- SIYEON PARKExecutive Officer
- Offering amount
- $1.3M
- Minimum investment
- $10K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$160KraisedJan 2023 · 2 investors · BiotechnologyRule 506(b)
▶$160KraisedJan 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Siyeon ParkExecutive Officer, Director
- Evan FeldmanDirector
- Saumya RawatDirector
- Offering amount
- $300K
- Amount sold
- $160K
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Pharmesol do?
- Pharmesol builds a network of AI agents that automate manual, fragmented processes across healthcare systems and workflows, aiming to make medications safer and easier for patients and clinicians. The platform handles routine operational tasks and turns interactions into insights for care teams.
- Who founded Pharmesol?
- Pharmesol was founded by Saumya Rawat.
- Who are Pharmesol's investors?
- Pharmesol's investors include Entrepreneurs Roundtable Accelerator (ERA), Ten VC.
- How much funding has Pharmesol raised?
- Pharmesol has disclosed $160K raised across 1 of its 2 known rounds.
- Where is Pharmesol headquartered?
- Pharmesol is headquartered in Coppell, US.